Pathophysiology of lipid-related disease


The Metabolic Bases of Cardiovascular Risk Group of the Sant Pau Hospital Research Institute, is an interdisciplinary and translational research team that works in the field of cardiovascular diseases related to metabolic disorders such as dyslipidemia, diabetes mellitus, obesity, dementias, or hyperhomocysteinemia, among others. The purpose of the group’s different studies and lines of research is to find new targeted therapies and / or biomarkers to reduce cardiovascular risk and Alzheimer’s disease in patients with these metabolic disorders, as well as improve the diagnosis and control of patients.

Main lines of Research and Innovation

  • Lipid and lipoprotein metabolism impairment in disease
  • Novel biomarkers and therapies related to cardiometabolic risk factors, including obesity, diabetes, nonalchoholic steatohepatitis and hyperhomocysteinemia
This site is registered on as a development site.

Aquest lloc web utilitza cookies per millorar l'experiència de navegació i realitzar tasques analítiques. Si continues navegant, considerem que n’acceptes l’ús. Més informació